Best Myeloma hematologist-oncologists in Barcelona: TOP 5 doctors

• Specializes in advanced Myeloma treatment methods, ensuring personalized care.
• Utilizes stem cell transplantation, targeted therapy, and radiation to combat Myeloma.
• International experience in Europe and America enhances diverse treatment approaches.
• Holds critical certifications in Hematology and Pediatric Hemato-Oncology.
• Member of prestigious medical societies, staying abreast of Myeloma research.
• Offers online consultations for global patient accessibility.
• Conversant in numerous languages, facilitating communication with a wide patient base.

• Specializes in Myeloma treatment, utilizing advanced methods.
• Myeloma therapies include stem cell transplant, chemotherapy, and targeted therapy.
• International practice in countries with leading cancer research.
• Certified Hematologist, expertise in transplantation.
• Member of professional hematological societies, ensuring up-to-date practices.
• Offers online consultations for Myeloma patients worldwide.
• Speaks multiple languages, enhancing patient comfort and understanding.

• Dr. Jaume Mora Graupera specializes in Myeloma treatment.
• He employs chemotherapy, stem cell transplants, and targeted therapy.
• Trained in the USA at Weill Cornell Medicine and Memorial Sloan Kettering.
• Directs Hematology Oncology Department at Sant Joan De Déu in Barcelona.
• Member of the American Society of Clinical Oncology, representing high professionalism.
• Offers remote consultations for Myeloma patients, enhancing accessibility.
• Fluent in English and Spanish, facilitating communication with diverse patients.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.